Recent Posts

News, Investor
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Posted 13th April 2021

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia

Read More
News , Blog , Patient Advocacy
Making information about genomic medicine accessible to all 
Posted 9th April 2021

Making information about genomic medicine accessible to all 

Read More
News , Investor
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Posted 6th April 2021

Congenica Appoints Jayesh Pankhania as Chief Financial Officer

Read More
News , Blog
Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Posted 31st March 2021

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Read More
News , Investor
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Posted 25th March 2021

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Read More
News
Congenica signs distribution agreement with AmpliTech in France
Posted 15th March 2021

Congenica signs distribution agreement with AmpliTech in France

Read More
News , Investor
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Posted 1st March 2021

Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Read More
News , Blog , Product
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Posted 24th February 2021

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More
News , Investor
David Atkins joins the National Genomics Board as BIA representative
Posted 18th February 2021

David Atkins joins the National Genomics Board as BIA representative

Read More
News , Investor
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Posted 3rd February 2021

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More
News
Congenica Contributes to Key Priority within UK Rare Disease Framework
Posted 27th January 2021

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More
previous
1 2 3 4 5
... 10 next
News , Investor
Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia
Posted 13th April 2021

Congenica and Camtech Diagnostics agree strategic partnership to support genomic analysis expansion in Asia

Read More
News , Blog , Patient Advocacy
Making information about genomic medicine accessible to all 
Posted April Apr 9th 2021

Making information about genomic medicine accessible to all 

Read More
News , Investor
Congenica Appoints Jayesh Pankhania as Chief Financial Officer
Posted April Apr 6th 2021

Congenica Appoints Jayesh Pankhania as Chief Financial Officer

Read More
News , Blog
Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing
Posted March Mar 31st 2021

Institute of Immunology and Genetics in Kaiserslautern selects Congenica to accelerate its whole exome sequencing

Read More
News , Investor
Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients
Posted March Mar 25th 2021

Sanford Health partners with Congenica to provide answers for undiagnosed rare disease patients

Read More
News
Congenica signs distribution agreement with AmpliTech in France
Posted March Mar 15th 2021

Congenica signs distribution agreement with AmpliTech in France

Read More
News , Investor
Congenica Appoints Kamraan Shariff as Chief Business Development Officer
Posted March Mar 1st 2021

Congenica Appoints Kamraan Shariff as Chief Business Development Officer

Read More
News , Blog , Product
Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants
Posted February Feb 24th 2021

Achieving the highest diagnostic yield possible with phenotype-based prioritization of variants

Read More
News , Investor
David Atkins joins the National Genomics Board as BIA representative
Posted February Feb 18th 2021

David Atkins joins the National Genomics Board as BIA representative

Read More
News , Investor
Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology
Posted February Feb 3rd 2021

Congenica Enters Cancer Collaboration with University of Glasgow Spinout Gabriel Precision Oncology

Read More
News
Congenica Contributes to Key Priority within UK Rare Disease Framework
Posted January Jan 27th 2021

Congenica Contributes to Key Priority within UK Rare Disease Framework

Read More
previous
1 2 3 4 5
... 10 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.